Matthew Pauls

Director · 4 filings · Latest: Jun 29, 2026

PALVELLA THERAPEUTICS, INC.

Pelthos Therapeutics Inc.

SOLENO THERAPEUTICS INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
PTHS	Matthew Pauls	Director	Apr 2, 2026	Sale	$20.92	786	$16.4K	15,150	Apr 6 9:02 PM
SLNO	Matthew Pauls	—	Mar 28, 2025	Proposed Sale	$67.39	5,937	$400.1K	—	Mar 28 4:45 PM
SVRA	Pauls Matthew	—	Dec 16, 2024	Proposed Sale	$3.31	54,702	$180.8K	—	Dec 16 10:13 PM